Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Greenway Greenhouse Cannabis Corporation is a Canadian federally licensed cultivator and processor of greenhouse-grown cannabis focused on the Canadian market, with expanding international wholesale activity. The company operates cultivation, propagation, and processing facilities in Ontario and emphasizes high-yield, low-cost greenhouse production, nursery propagation, and dried flower supply. Greenway has been building commercial traction through domestic wholesale sales and international medical cannabis channels, including a supply agreement with UK-based 4C Labs. Its business is centered on commercial cannabis production rather than traditional drug development, so it does not have a conventional clinical-stage biotech pipeline. The company is publicly listed in Canada and also quoted in the U.S. OTC market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Greenway Greenhouse Cannabis Corporation.